Cargando…
Iron Therapy in Chronic Kidney Disease: Days of Future Past
Anemia affects millions of patients with chronic kidney disease (CKD) and prompt iron supplementation can lead to reductions in the required dose of erythropoiesis-stimulating agents, thereby reducing medical costs. Oral and intravenous (IV) traditional iron preparations are considered far from idea...
Autores principales: | Lee, Kuo-Hua, Ho, Yang, Tarng, Der-Cherng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863960/ https://www.ncbi.nlm.nih.gov/pubmed/33498292 http://dx.doi.org/10.3390/ijms22031008 |
Ejemplares similares
-
Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease
por: Wu, Chia-Lin, et al.
Publicado: (2020) -
Antithrombotic Therapy for Chronic Kidney Disease Patients With Concomitant Atrial Fibrillation and Coronary Artery Disease
por: Lee, Kuo-Hua, et al.
Publicado: (2021) -
Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease
por: Hung, Szu‐Chun, et al.
Publicado: (2017) -
Beyond a Measure of Liver Function—Bilirubin Acts as a Potential Cardiovascular Protector in Chronic Kidney Disease Patients
por: Tsai, Ming-Tsun, et al.
Publicado: (2018) -
The Anti-Inflammatory, Anti-Oxidative, and Anti-Apoptotic Benefits of Stem Cells in Acute Ischemic Kidney Injury
por: Lee, Kuo-Hua, et al.
Publicado: (2019)